These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9485529)

  • 1. Effect of sleep deprivation on serum influenza-specific IgG.
    Renegar KB; Floyd R; Krueger JM
    Sleep; 1998; 21(1):19-24. PubMed ID: 9485529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of short-term sleep deprivation on murine immunity to influenza virus in young adult and senescent mice.
    Renegar KB; Floyd RA; Krueger JM
    Sleep; 1998 May; 21(3):241-8. PubMed ID: 9595602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of immunity to influenza virus infection in the respiratory tract following sleep disturbance.
    Brown R; Pang G; Husband AJ; King MG
    Reg Immunol; 1989; 2(5):321-5. PubMed ID: 2562046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of influenza viral infection through the murine respiratory tract: the protective role of sleep deprivation.
    Renegar KB; Crouse D; Floyd RA; Krueger J
    Sleep; 2000 Nov; 23(7):859-63. PubMed ID: 11083594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM.
    Kris RM; Asofsky R; Evans CB; Small PA
    J Immunol; 1985 Feb; 134(2):1230-5. PubMed ID: 2981265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Emergency prophylactic effects of the avian influenza virus immunized serum on the infected mice].
    Wang CY; Wang HL; Feng N; Yang ST; Gao YW; Wang TC; Zou XH; Xia XZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Nov; 42(11):814-7. PubMed ID: 19176141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
    Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice.
    Hovden AO; Cox RJ; Madhun A; Haaheim LR
    Scand J Immunol; 2005 Oct; 62(4):342-52. PubMed ID: 16253121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in mice.
    Takahashi Y; Hasegawa H; Hara Y; Ato M; Ninomiya A; Takagi H; Odagiri T; Sata T; Tashiro M; Kobayashi K
    J Infect Dis; 2009 Jun; 199(11):1629-37. PubMed ID: 19385735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
    Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
    Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection.
    Quan FS; Compans RW; Cho YK; Kang SM
    Vaccine; 2007 Jan; 25(2):272-82. PubMed ID: 16945454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice.
    Qiu M; Fang F; Chen Y; Wang H; Chen Q; Chang H; Wang F; Wang H; Zhang R; Chen Z
    Biochem Biophys Res Commun; 2006 May; 343(4):1124-31. PubMed ID: 16580631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in antibody responses of mice to intranasal or intraperitoneal immunization with influenza A virus and vaccination with subunit influenza vaccine.
    Fislová T; Sládková T; Gocník M; Mucha V; Varecková E; Kostolanský F
    Acta Virol; 2005; 49(4):243-50. PubMed ID: 16402681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein.
    Pertmer TM; Robinson HL
    Virology; 1999 May; 257(2):406-14. PubMed ID: 10329551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A vaccination strategy to enhance mucosal and systemic antibody and T cell responses against influenza.
    Vajdy M; Baudner B; Del Giudice G; O'Hagan D
    Clin Immunol; 2007 May; 123(2):166-75. PubMed ID: 17349825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient vagina-to-lower respiratory tract immune trafficking in a murine model of influenza A virus infection.
    Garulli B; Meola M; Stillitano MG; Kawaoka Y; Castrucci MR
    Virology; 2007 May; 361(2):274-82. PubMed ID: 17222437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
    Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.